SEARCH

SEARCH BY CITATION

References

  • 1
    He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China. N Engl J Med 2005; 353: 11241134.
  • 2
    Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004; 292: 14331439.
  • 3
    Thun MJ, Apicella LF, Henley SJ. Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. JAMA 2000; 284: 706712.
  • 4
    Janson C, Chinn S, Jarvis D, Zock JP, Toren K, Burney P. Effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey: a cross-sectional study. Lancet 2001; 358: 21032109.
  • 5
    Wilson PW. Smoking, smoking cessation, and risk of cardiovascular disease. Curr Treat Options Cardiovasc Med 2006; 8: 276281.
  • 6
    Abdullah AS, Husten CG. Promotion of smoking cessation in developing countries: a framework for urgent public health interventions. Thorax 2004; 59: 623630.
  • 7
    Alebiosu CO. An update on ‘progression promoters’ in renal diseases. J Natl Med Assoc 2003; 95: 3042.
  • 8
    Malfertheiner P, Schutte K. Smoking–a trigger for chronic inflammation and cancer development in the pancreas. Am J Gastroenterol 2006; 101: 160162.
    Direct Link:
  • 9
    Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005; 293: 17371745.
  • 10
    Agarwal R. Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy. BMC Nephrol 2005; 6: 13.
  • 11
    Liu PY, Li YH, Chan SH, Lin LJ, Wu HL, Shi GY, et al. Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome. Am J Cardiol 2006; 98: 10121017.
  • 12
    Taal MW. Slowing the progression of adult chronic kidney disease: therapeutic advances. Drugs 2004; 64: 22732289.
  • 13
    Johnson DW. Evidence-based guide to slowing the progression of early renal insufficiency. Intern Med J 2004; 34: 5057.
  • 14
    Schnoll RA, Lerman C. Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opin Emerg Drugs 2006; 11: 429444.
  • 15
    Whitehead TP, Robinson D, Allaway SL. The effects of cigarette smoking and alcohol consumption on serum liver enzyme activities: a dose-related study in men. Ann Clin Biochem 1996; 33(Pt 6): 530535.
  • 16
    El-Zayadi AR. Heavy smoking and liver. World J Gastroenterol 2006; 12: 60986101.
  • 17
    Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. HEPATOLOGY 2005; 42: 11941202.
  • 18
    Corrao G, Lepore AR, Torchio P, Valenti M, Galatola G, D'Amicis A, et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease. Eur J Epidemiol 1994; 10: 657664.
  • 19
    Dev A, Patel K, Conrad A, Blatt LM, McHutchison JG. Relationship of smoking and fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2006; 4: 797801.
  • 20
    Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. HEPATOLOGY 2001; 34: 121125.
  • 21
    Pessione F, Ramond MJ, Peters L, Pham BN, Batel P, Rueff B, et al. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int 2003; 23: 4553.
  • 22
    El-Zayadi A, Selim O, Hamdy H, El-Tawil A, Badran HM, Attia M, et al. Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patients. World J Gastroenterol 2004; 10: 29632966.
  • 23
    Fujita Y, Shibata A, Ogimoto I, Kurozawa Y, Nose T, Yoshimura T, et al. The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br J Cancer 2006; 94: 737739.
  • 24
    Pungpapong S, Manzarbeitia C, Ortiz J, Reich DJ, Araya V, Rothstein KD, et al. Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation. Liver Transpl 2002; 8: 582587.
  • 25
    Yuen ST, Gogo AR Jr, Luk IS, Cho CH, Ho JC, Loh TT. The effect of nicotine and its interaction with carbon tetrachloride in the rat liver. Pharmacol Toxicol 1995; 77: 225230.
  • 26
    Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, et al. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 2006; 291: L46L57.
  • 27
    Jaimes E, Tian RX, Raij L. Nicotine: The Link Between Cigarette Smoking and the Progression of Renal Injury? Am J Physiol Heart Circ Physiol 2006, August 18 [Epub ahead of print].
  • 28
    El-Zayadi AR, Selim O, Hamdy H, El-Tawil A, Moustafa H. Heavy cigarette smoking induces hypoxic polycythemia (erythrocytosis) and hyperuricemia in chronic hepatitis C patients with reversal of clinical symptoms and laboratory parameters with therapeutic phlebotomy. Am J Gastroenterol 2002; 97: 12641265.
    Direct Link:
  • 29
    Zhang WZ, Venardos K, Chin-Dusting J, Kaye DM. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress. Hypertension 2006; 48: 278285.
  • 30
    Anan F, Takahashi N, Shinohara T, Nakagawa M, Masaki T, Katsuragi I, Tanaka K, et al. Smoking is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Eur J Clin Invest 2006; 36: 459465.